We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Impax Draws Wide Support in FTC Dispute Over Opana ER Settlement
Impax Draws Wide Support in FTC Dispute Over Opana ER Settlement
Generic drugmakers, antitrust economists and a public-interest law firm that defends free enterprise all supported Impax in amicus briefs filed in a federal appeals court, arguing that the Federal Trade Commission erred in its ruling that Impax’s 2010 settlement with Endo Pharmaceuticals was anticompetitive.